• PainChek Ltd requests trading halt pending announcement of material capital raise
• Trading halt to remain in place until announcement is made or market open on Monday, 28 July 2025
• PainChek is a regulatory-cleared medical device for pain assessment

PainChek Ltd (ASX: PCK) has requested a trading halt in its securities, effective from the commencement of trading on Thursday, 24 July 2025. The company is seeking the trading halt pending an announcement regarding a material capital raise. The trading halt will remain in place until the earlier of: (1) PainChek making an announcement regarding the proposed capital raising; (2) before the opening of trading on Monday, 28 July 2025; or (3) PainChek separately requesting that the trading halt be lifted. PainChek considers the trading halt necessary as otherwise trading in its securities would continue on an uninformed basis. PainChek is a company that has developed the world's first regulatory-cleared medical device for the assessment of pain, enabling best-practice pain management for people living with pain in any environment, from those who cannot reliably self-report their pain to those whose ability to self-report fluctuates. The PainChek app combines the company's AI pain assessment tool with the Numerical Rating Scale, allowing accurate, consistent pain assessment at the point of care.